Sygnis AG (Sygnis), formerly Sygnis Pharma AG is a developer of novel products and tools in the field of molecular biology. The company undertakes development and marketing of new molecular biological technologies for DNA amplification and sequencing. Its offers products such as single cell WGA kits, WGA kits, RCA kit, DNA polymerase, one step RT-PCR kit and one step RT-qPCR kit, single cell reverse transcriptase RNaseH+ and RNaseH- kits, among others. The company’s single cell WGA kit is based on its proprietary primpol technology. Its products are also based on retrotranscriptase technology. Its polymerases provides a wide range of applications for DNA amplification, repair, sequencing, detection and modification of genetic targets of clinical value. The company has operations in Germany and Spain. Sygnis is headquartered in Heidelberg, Germany.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope
Reasons to buy
Note: Some sections may be missing if data is unavailable for the company
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Sygnis AG
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Sygnis AG Company Overview
- Sygnis AG Company Snapshot
- Sygnis AG Pipeline Products and Ongoing Clinical Trials Overview
- Sygnis AG - Pipeline Analysis Overview
- Sygnis AG - Key Facts
- Sygnis AG - Major Products and Services
- Sygnis AG Pipeline Products by Development Stage
- Sygnis AG Pipeline Products Overview
- Lyophilized Kit Versions
- Lyophilized Kit Versions Product Overview
- TruePrime FFPE DNA Amplification Kit
- TruePrime FFPE DNA Amplification Kit Product Overview
- TruePrime Floating DNA Amplification Kit
- TruePrime Floating DNA Amplification Kit Product Overview
- TruePrime Single Cell WTA Kit
- TruePrime Single Cell WTA Kit Product Overview
- Sygnis AG - Key Competitors
- Sygnis AG - Key Employees
- Sygnis AG - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Sygnis AG, Recent Developments
- May 11, 2018: Sygnis Reports Strong Financial Results for First Quarter of 2018
- Apr 25, 2018: SYGNIS announces financial results for fiscal year 2017
- Mar 15, 2018: SYGNIS announces completion of Sales and Marketing team restructuring to support continued strong revenue growth
- Dec 06, 2017: SYGNIS Launches TruePrime Apoptotic Cell Free DNA Amplification Kit for the Liquid Biopsy Market
- Dec 06, 2017: SYGNIS launches TruePrime apoptotic cell free DNA amplification kit for the liquid biopsy market
- Nov 08, 2017: SYGNIS reports financial results for the third quarter and first nine months of 2017
- Oct 24, 2017: SYGNIS announces the launch of the Universal Lateral Flow Assay kit and associated patent filing
- Aug 03, 2017: SYGNIS reports financial results for the second quarter and first six months of 2017
- Jun 06, 2017: SYGNIS announces Management and Supervisory Board changes
- May 11, 2017: SYGNIS reports financial results for first quarter of 2017
- Appendix
- Methodology
- About
- Contact
- Disclaimer
List of Tables
- Sygnis AG Pipeline Products and Ongoing Clinical Trials Overview
- Sygnis AG Pipeline Products by Equipment Type
- Sygnis AG Pipeline Products by Indication
- Sygnis AG, Key Facts
- Sygnis AG, Major Products and Services
- Sygnis AG Number of Pipeline Products by Development Stage
- Sygnis AG Pipeline Products Summary by Development Stage
- Lyophilized Kit Versions - Product Status
- Lyophilized Kit Versions - Product Description
- TruePrime FFPE DNA Amplification Kit - Product Status
- TruePrime FFPE DNA Amplification Kit - Product Description
- TruePrime Floating DNA Amplification Kit - Product Status
- TruePrime Floating DNA Amplification Kit - Product Description
- TruePrime Single Cell WTA Kit - Product Status
- TruePrime Single Cell WTA Kit - Product Description
- Sygnis AG, Key Employees
- Sygnis AG, Other Locations
- Sygnis AG, Subsidiaries
- Glossary
List of Figures
- Sygnis AG Pipeline Products by Equipment Type
- Sygnis AG Pipeline Products by Development Stage
Samples
LOADING...
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Mologen AG
- MorphoSys AG
- Epigenomics AG
